SkinBioTherapeutics plc (LON:SBTX – Get Free Report)’s stock price fell 1.7% during mid-day trading on Monday . The company traded as low as GBX 16.50 ($0.21) and last traded at GBX 17.20 ($0.22). 759,267 shares traded hands during mid-day trading, an increase of 41% from the average session volume of 537,520 shares. The stock had previously closed at GBX 17.50 ($0.22).
SkinBioTherapeutics Stock Down 1.7 %
The firm has a fifty day moving average of GBX 16.54 and a 200-day moving average of GBX 13.36. The company has a quick ratio of 10.01, a current ratio of 6.57 and a debt-to-equity ratio of 2.66. The firm has a market cap of £38.89 million, a P/E ratio of -860.00 and a beta of 2.01.
About SkinBioTherapeutics
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Further Reading
- Five stocks we like better than SkinBioTherapeutics
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- When to Sell a Stock for Profit or Loss
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Canadian Penny Stocks: Can They Make You Rich?
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
